Category Archives: Alternative Medicine

Complementary and Alternative Medicine Market 2020

This report studies the Complementary and Alternative Medicine Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Complementary and Alternative Medicine Market analysis segmented by companies, region, type and applications in the report.

The major players covered in Complementary and Alternative Medicine Market Columbia Nutritional, Herb Pharm, Herbal Hills, Helio USA, Deepure Plus, Nordic Naturals, Pure encapsulations, Iyengar Yoga Institute, John Schumachers Unity Woods Yoga Center, Yoga Tree, The Healing Company, and Quantum Touch

The final report will add the analysis of the Impact of Covid-19 in this report Complementary and Alternative Medicine industry.

Get a Free Sample Copy @ https://www.reportsandmarkets.com/sample-request/global-complementary-and-alternative-medicine-market-size-status-and-forecast-2019-2025-one?utm_source=3wnews&utm_medium=36

Complementary and Alternative Medicine Market continues to evolve and expand in terms of the number of companies, products, and applications that illustrates the growth perspectives. The report also covers the list of Product range and Applications with SWOT analysis, CAGR value, further adding the essential business analytics. Complementary and Alternative Medicine Market research analysis identifies the latest trends and primary factors responsible for market growth enabling the Organizations to flourish with much exposure to the markets.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Research objectives:

To study and analyze the global Complementary and Alternative Medicine market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2026.

To understand the structure of Complementary and Alternative Medicine market by identifying its various sub segments.

Focuses on the key global Complementary and Alternative Medicine players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Complementary and Alternative Medicine with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Complementary and Alternative Medicine submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

The Complementary and Alternative Medicine Market research report completely covers the vital statistics of the capacity, production, value, cost/profit, supply/demand import/export, further divided by company and country, and by application/type for best possible updated data representation in the figures, tables, pie chart, and graphs. These data representations provide predictive data regarding the future estimations for convincing market growth. The detailed and comprehensive knowledge about our publishers makes us out of the box in case of market analysis.

Table of Contents: Complementary and Alternative Medicine Market

Chapter 1: Overview of Complementary and Alternative Medicine Market

Chapter 2: Global Market Status and Forecast by Regions

Chapter 3: Global Market Status and Forecast by Types

Chapter 4: Global Market Status and Forecast by Downstream Industry

Chapter 5: Market Driving Factor Analysis

Chapter 6: Market Competition Status by Major Manufacturers

Chapter 7: Major Manufacturers Introduction and Market Data

Chapter 8: Upstream and Downstream Market Analysis

Chapter 9: Cost and Gross Margin Analysis

Chapter 10: Marketing Status Analysis

Chapter 11: Market Report Conclusion

Chapter 12: Research Methodology and Reference

Key questions answered in this report

What will the market size be in 2026 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

Inquire More about This https://www.reportsandmarkets.com/enquiry/global-complementary-and-alternative-medicine-market-size-status-and-forecast-2019-2025-one?utm_source=3wnews&utm_medium=36

About Us:

Reports and Markets is not just another company in this domain but is a part of a veteran group called Algoro Research Consultants Pvt. Ltd. It offers premium progressive statistical surveying, market research reports, analysis & forecast data for a wide range of sectors both for the government and private agencies all across the world. The database of the company is updated on a daily basis. Our database contains a variety of industry verticals that include: Food Beverage, Automotive, Chemicals and Energy, IT & Telecom, Consumer, Healthcare, and many more. Each and every report goes through the appropriate research methodology, Checked from the professionals and analysts.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

View post:

Impact of COVID-19 Outbreak on Complementary and Alternative Medicine Market to Witness Columbia Nutritional, Herb Pharm, Herbal Hills, Helio USA,...

The inherent, ineluctable unpredictability of biology can be the basis for biological patent claims being non-obvious (lacking the requisite "reasonable expectation of success"; see, e.g., OSI Pharmaceuticals v. Apotex) and for the greater quantum of disclosure necessary to satisfy the written description and enablement requirements of 112 (see, e.g., Amgen v. Sanofi), despite complaints from the life sciences patent bar that these increased requirements are improper doctrinally and unfair. These two different characteristics can be frequently in tension for patenting in the life sciences, it being difficult to maintain on the one hand that there is insufficient expectation of success for a claim to be obvious and on the other hand that deficiencies in disclosure can be appropriately supplemented by the knowledge of one of ordinary skill.

This unpredictability was illustrated in a paper recently published in Nature Medicine, entitled "Common germline variants of the humanAPOE gene modulate melanoma progression and survival." These authors* showed (somewhat paradoxically) that one variant of the human APOE gene (APOE2) was associated with a propensity for tumor cells to metastasize, while a different variant (APOE4), which has been known for several years to be associated with development of Alzheimer's disease (see Strittmatter et al., 1993, Proc. Natl. Acad. Sci. USA 90: 1977-81), exhibited a metastasis-inhibiting effect (and APOE2 itself can have a protective effect on development of late-onset Alzheimer's; see Corder et al., 1994, Nat. Genet. 7: 180-84).

The experiments were performed in mice expressing human APOE4 or APOE2 by genetic replacement of the mouse analogs. Differences in melanoma tumor growth in these two mouse strains carrying these different human APOE genes were shown by comparing mouse melanoma tumor growth as shown in this Figure:

(where YUMM3.3 and YUMMER1.7 are murine melanoma cell lines).

The protective effects against metastasis of APOE4 were compared with APOE2 in these mice was demonstrated by tail vein injection of B16F10 melanoma cells, an established metastasis animal model. The human APOE4-bearing mice had a phenotype of enhanced anti-tumor immune response and improved outcomes under PD1 immune checkpoint blockade.

Because APOE was known to have modulatory effects on immune response, flow cytometric analysis of APOE gene variants in mice was performed and showed "enhanced recruitment of CD45+ leukocytes in animals bearing various melanoma tumors in APOE4 mice compared with APOE2 mice." Proportions of immune suppressor cells (Ly6G+ granulocytic myeloid-derived suppressor cells) were found to be diminished in APOE4-bearing mice, while these mice showed increased proportions of antitumor effector cells such as natural killer (NK) cells and CD8+ T cells. These results were confirmed by single-cell RNA sequencing for detecting lineage-specific gene expression. Further experiments showed that T cell depletion "completely abrogated" differences in melanoma tumor growth between human APOE4- and human APOE2-bearing mice. The authors concluded that "[t]hese data suggest that APOEgenotype modulated both the abundance and the functional state of the tumor immune microenvironment, with theAPOE4variant eliciting an enhanced anti-tumor immune profile relative to theAPOE2 variant." These authors also showed that APOE4 suppressed melanoma cell invasion and endothelial recruitment (involved in angiogenesis), which was consistent with lower blood vessel density in APOE4 mice.

In addition to these mouse studies, the authors assessed APOE genotype association in melanoma human patients from The Cancer Genome Atlas (TCGA). Neither of these APOE variants was enriched in the database, which the authors said indicated neither gene was involved in increased melanoma incidence. However, APEO4 carriers had improved survival, with 10.1 years for these patients versus 2.1 years for APEO2 carriers. This outcome was surprising due to the reduced longevity associated with APOE4 carriers, which the authors attributed to the high rates of melanoma-associated death. These results demonstrated that "germline genetic variants of APOEdifferentially associated with survival in patients with advanced melanoma who were at increased risk for melanoma-associated death and metastasis."

PD-1 immunotherapy is a commonly used treatment for melanoma, and "APOE4mice survived significantly longer thanAPOE2mice upon anti-PD1 treatment, suggesting thatAPOE genotype modulates melanoma outcome also in the context of immunotherapy," according to the results shown in the paper. In humans, "APOE4andAPOE2carriers exhibited the longest and shortest survival outcomes, respectively, upon anti-PD1 therapy," consistent with the results in mice.

The final set of experimental results reported in this paper involved pharmacologic activation of APOE through liver X receptors, which are "nuclear hormone receptors that transcriptionally activate several genes implicated in cholesterol and lipid metabolism, includingAPOE." In mice, this effect was completely abrogated in APOE2 mice but showed "robust anti-tumor effects" upon treatment in APOE4 mice. The authors concluded from these results that "distinct APOEgenotypes elicited differential responsiveness to LXR agonistic therapy and might serve as potential genetic biomarkers for current clinical efforts investigating the use of LXR agonism in cancer therapy."

The authors provide the following context for the results set forth in their paper:

Our findings have several potential clinical implications. Most importantly, they suggest that common germline variants might serve as biomarkers to identify patients with melanoma who are at high risk for metastatic relapse and melanoma-associated death for treatment with adjuvant systemic therapy. Notably, these clinical association findings will need to be assessed in prospective studies. It will be important to also assess the effect of APOE genotype on the outcome of additional cancer types. More generally, our findings support the notion that hereditary germline variants in the same gene can positively or negatively affect future progression and survival outcomes and responsiveness to therapy in a common human malignancy.

Authors: Benjamin N. Ostendorfa,Jana Bilanovica, Nneoma Adakua,Kimia N. Tafreshiana,Bernardo Tavoraa,Roger D. Vaughanb & Sohail F. Tavazoiea

a Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USAb Department of Biostatistics, The Rockefeller University, New York, NY, USA

Read the original:

Alternative APOE Gene Variants Associated with Different Diseases of Aging - JD Supra

695 Views

Homeopathy is a pseudoscientific system of alternative medicine. It was created in 1796. In this pandemic, where many doctors and scientists are failed to find the Corona Virus Pandemic, there are some doctors are experts who believe homeopathy is the panacea of this fatal virus. Homeopathy has proved itself in several epidemics. It boosts immunity and increases the growth of the good bacteria in our body, which helps us to fight against any virus.

Father of Homeopathy, Dr. Samuel Hahnemann coined the phrase genus epidemics, which indicated the remedy which can cure any epidemic. Homeopathy has also helped cure the Spanish flu epidemic which happened after the First World War, plus, it has also proved its significance in curbing dengue and Swine flu.

It is published by the Ministry of AYUSH that homeopathic and Unani medicines could be effective in the prevention of novel coronavirus pandemic. It is recommended that homeopathic medicine Arsenical album 30 could be taken empty stomach daily for three days as a prophylactic medicine against the infection.

As we all know that, it has been more than three months for us fighting with this contagious Coronavirus disease. With the zeal to find the drug for this virus, one of the practioner of Homeopathy said that they should also be given the chance of testing the drug of this virus and they should also be considered on the same page as of other doctors. IANS, Dr. Kushal Banerjee, one of the largest and oldest practitioners of India and abroad, while speaking to News 18, has said that Homeopathy has a good track record with epidemics and infectious disease, therefore people should people should keep their biases aside and should try all treatments possible to save lives amid this pandemic.

But in the meantime, the major concern is, whether homeopathy is medicine for novel coronavirus disease or not? To answer this question, Dr. Banerjee said that There is not much data available about COVID-19. Homeopathic medicines are also given even in ICU and in case of multiple organ failure, patients start recovering quickly. There are very effective medicines in homeopathy for respiratory disease. Right now it is important to provide benefits to as many patients as possible. He further added that he and his team are in the process of analyzing data.

We are also running an online survey to estimate the result of that prescription. The database of 15000 people is ready. It will be the second-largest study on COVID-19 anywhere in the world; the largest is of 20000 patients. We have got responses from patients from 12 countries including the US, Italy, Norway, and Sweden. These data are looking very promising.

There are many myths about Homeopathy, and one of the greatest myths is that it a very long procedure and it will take a long time to cure. This myth has been neglected by Homeopathy doctors. According to them, the time depends on the disease. Homeopathy can cure some diseases in 2-3 hours and whereas some diseases can be cured within 15 minutes. They are also given to the patients on a ventilator. Homeopathic medicines are very effective, especially for respiratory disease.

Allopathic medicines may work a little bit faster as compared to Homeopathy, but it comes with some side-effects. Whereas, Homeopathic medicines are effective as well as there is no side-effect of them. Moreover, they are very beneficial to respiration. Thus, it may be concluded that now it time to bring Homeopathy in the fight against the Coronavirus.

Summary

Article Name

Is it Time to Introduce Homeopathy and Alternative Medicines to Fight against Covid-19?

Description

It is published by the Ministry of AYUSH that homeopathic and Unani medicines could be effective in the prevention of novel coronavirus pandemic. It is recommended that homeopathic medicine Arsenical album 30 could be taken empty stomach daily for three days as a prophylactic medicine against the infection.

Author

Kanupriya

Publisher Name

THE POLICY TIMES

Publisher Logo

See the original post here:

Is it Time to Introduce Homeopathy and Alternative Medicines to Fight against Covid-19? - thepolicytimes.com

Alternative medical therapies are back in business and increasingly gaining traction from the public with the easing of Covid-19 restrictions. Stress management therapies and immune system boosters are seeing a rise in takers after Dubai resumed complementary medicine therapies.

Health care professionals have welcomed this move as it also brings the much needed economic relief to most clinics as well as reassuring patients with their continued treatment which was disrupted due to Covid-19 pandemic.

To put patients at ease and keep them safe, these clinics are implementing a slew of hygiene measures as per the guidelines laid down by the Dubai Health Authority (DHA).

"With all our walk-in patients we first check the temperature and in case, there is any doubt patients are sent for swab tests. Apart from that all other precautionary measures are in place. We have also noticed there are too many people who are in a panic mode now. So, special ayurvedic treatment or therapies focused on this aspect is clearly on the rise," said Shameema Abdul Nazar, ayurvedic practitioner at Metro Medical Centre.

"Health awareness for all age groups is becoming important which entails different herbal preparations, yoga therapy or breathing exercises pertaining to strengthening one's lungs, managing panic and improving sleep are seeing demand," she added.

Life coach and energy healer Girish Hemnani said: "It's encouraging to see more individuals seeking to learn and practice breath work and energy healing as it is instrumental in increasing the immune system. As an energy healer, for the first time I am witnessing that individuals are looking for protective measures and natural ways to increase and maintain their immune system. Prana (life force energy, also known as chi) is being well understood now and various techniques to increase the prana level are being practised."

Homeopathic doctors are also observing a sizeable increase in demand now. "The demand for general immunisation treatment or a need for immunity booster is witnessing a surge. People with active fever are asked a set of questions on the phone first and are routed differently depending on the nature of their replies," said Dr Rozina Baig Zaheer, homeopathic practitioner at Zia Medical Centre.

"However, I am noticing an increase in anxiety cases these days. My patients are relieved that they can finally continue with their preexisting treatment related to a host of other problems. We are back to offering customised treatment on a case-by-case basis," she added.

Using natural herbs to cure different types of diseases, a traditional Chinese medicinal facility located in Dubai Healthcare City, continues to offer certain in-house procedures on an urgent basis. "We provide a complete array of services, from consultation, herbalism, acupuncture, acupressure, cupping and Tui-Na (remedial massage). But right now, patients are prioritised. For example, recently we've been treating a patient with facial paralysis. For all non-urgent cases, we use teleconsultation and delivering medicines at the patients' doorstep," said Deyuan Wei, director of Beijing Tong Ren Tang.

nandini@khaleejtimes.com

Continued here:

Easing of Covid-19 restrictions: More UAE residents explore alternative immunity boosters - Khaleej Times

Medical Economics and Specialdocs Consultants present a free webinar for physicians on the topic of: Now what? The Imminent Dangers and Emerging Opportunities for Physicians. The webinar is scheduled for June 17 at 7pm Eastern.

Click here to sign up for free!

Physicians have been at the forefront of unprecedented turmoil during the COVID-19 emergency. This crisis has compounded structural faults that have been consistently observed but inadequately addressed over the past decade.

Primary care physicians, in particular, have found themselves in turbulent times as office visits evaporated overnight due to shelter-in-place orders and patients understandable fear of potential infection. In response to decreased in-person visits, telehealth visits swelled to extraordinary levels, thanks in large part to temporary relaxation of regulations.

As a result, doctors have had to rethink staffing, real estate and other costs of providing care. They also should consider that there is no clear answer on how long the new guidelines and associated reimbursement rates for telehealth will remain in place. With so many unknown factors in play, physicians face an uncertain future.

Now what?

It is what many doctors are asking themselves, and it encapsulates several separate questions:

1.What is the next unforeseen and life-altering event I will need to address if I stick with the status quo?

2.What will the physician landscape look like in one, three or five years?

3.What should I do now?

Change will remain constant, and one of the seminal lessons of COVID-19 is that no one can perfectly predict how or when the next significant challenge will arise. Similarly, specific forecasts of the future state of healthcare are notoriously inaccurate. The best step toward an answer is to first observe principal trends and envision where independent primary care will fit within them. From there you can take actions to safeguard your practice from whatever may come next.

The challenges facing independent primary care physicians have beenwell documented, and if you are reading this article you likely already know the key clinical, financial and operational challenges of running your own practice (e.g., reimbursement declines, stagnating compensation, rising operating costs). Various market responses to these issues have emerged:

-Large medical groups and health systems continue toacquire and consolidate independent practices. OptumCare, the care delivery division of UnitedHealth Group, is the largest employer of physicians in United States with 48,000. HCA Healthcare and Kaiser Permanente have 38,000 and 23,000 physicians, respectively, and all are actively adding physicians to their rosters. Health systems across the country are rapidly acquiring remaining independent practices in their operating footprints. From 2012 to 2018, the number of hospital-owned physician practices increased from 35,700 to more than 80,000, and the number of hospital-employed physicians increased from 94,700 to 168,800. Consolidation by medical groups and health systems is expected to continue apace in the near term, despite the furloughing of physicians and other staff at hospitals across the country.

-New care models centered on membership and convenience are quickly forming. One Medical, Iora and others are among a growing number of corporate entities establishing practices across the country. These practices employ physicians and often partner with large health systems to integrate different primary care offerings into a health system, with services marketed both to employers and individuals. One Medical, which recently became a publicly-traded company and has 455,000 members, estimates that it has only captured between 1% and 3% share in each of its markets but they and similar companies have ambitions and funding aimed significantly higher than their current share.

-Alternative treatment sites have continued to grow over the past few years. Walgreens and Walmart have expanded both services and number of locations, and have made no secret of their ambitious goals for additional growth. According to Walmart, their prices are 30% to 50% lower than what patients would pay for comparable services at physician offices. The merger of CVS and Aetna has created another integrated care provider with broad consumer exposure and comprehensive population health capabilities CVS has more than 1,100 MinuteClinic locations and plans to open 1,500 HealthHUBs by 2021, offering more comprehensive services like chronic disease management, sleep apnea assessment, blood draws, and a care concierge to help patients find appropriate services.

The trends above, and the models at the center of those trends, each focus on different areas of the primary care market.

-Health systems and large corporate medical groups are targetingtraditional physician practiceswith broad patient bases and hope to consolidate the markets in which they operate.

-One Medical and similar providers have constructed models that focus onconvenience, cost and connectivity to providers, and ultimately aim to supplant incumbentmedical groups and independent physicians as the dominant primary care providers in their markets. They have also designed their offerings to appeal toyounger, healthier patientswith commercial insurance, leaving other patients to seek care elsewhere.

-CVS, Walmart and others are focused on making care easy, accessible and affordable, and keeping consumers within their retail ecosystems. These services are targeted towardcost-conscious patientswith low to average healthcare needs.

Meanwhile, payers, providers and other healthcare stakeholders are encouraging further migration to alternative reimbursement models. Prospective payment, value-based, capitation these will all continue to grow at the expense of fee-for-service. With more structured and complex payment arrangements, additional leverage will go to payers and providers with scale, not independent physicians. OptumCare already has two-thirds of its 48,000-physician network under capitated/risk-based contracts, with more likely. Rapidly growing companies like Bright Health are launching individual and Medicare Advantage plans by aligning with a single provider organization in each market. At the same time, advisory and advocacy groups are calling for different versions of aPrimary Care Marshall Planto increase the amount of prospective and value-based payments for primary care.

Add to this the accelerated adoption of telehealth and recent estimates that the telehealth market could grow from $3 billion to $250 billion in the near term (potentially converting 20% of outpatient care to virtual settings). While patients will certainly benefit from some aspects of expanded telehealth, large physician groups, payers and telehealth providers stand to gain the most in this scenario with additional leverage in the market again, at the expense of independent physicians and smaller provider and payer entities.

So, back to that question: Now what?

The options for independent physicians can be grouped into two broad categories: employed positions and independence with some modification. For physicians comfortable with an employed setting, the choices are broader than ever it is no longer just large health systems and physician groups employing doctors. New entrants like those mentioned above provide additional possibilities for doctors uninterested in independent practice, and may better match certain doctors preferences and goals.

But for physicians committed to their independence, change is necessary. Practice management companies offer a route that preserves some level of independence. However, these typically require the use of outside care teams and resources, and principally focus on maximizing fee-for-service revenue.

A more comprehensive solution can be found with membership medicine (e.g., concierge medicine and direct primary care), truly distinct practice models that minimize reliance on fee-for-service income and offer greater operational and clinical flexibility. The COVID-19 emergency is a stark reminder of the precarious state of primary care and its reliance on revenue from office visits. With nearly all healthcare stakeholders promoting payment structures that require physicians to understand and take on risk, individual physicians with limited leverage are best served by aresilient concierge modelthat can meet their clinical, financial and operational goals.

Independent physicians are justifiably unsure of the future, and fear of choosing the wrong path is understandable. However, preserving the status quo will not preserve options for later. The primary care world is evolving more quickly than at any period in recent history due to COVID-19 and all the factors discussed above.Independent doctors with strong practices should recognize this as a pivotal moment in their personal and professional timeline, evaluate their options, commit to a decision, and act NOW.

By Dave Farr, Vice President of Business Development, Specialdocs, a pioneering concierge practice transition and management company established in 2002, helping physicians nationwide transform their practices with a customized and sustainable concierge model.

Continue reading here:

Now what? The imminent dangers and emerging opportunities for physicians - Medical Economics

Order Reprints...

June 12, 2020

Fitness clubs, once considered a less appealing option for retailer center owners, became one of the hottest tenant classes before stay-at-home mandates shuttered most of them amid the COVID-19 pandemic. Post-pandemic, the International Council of Shopping Centers (ICSC) advises landlords to consider not only gyms but also the broader spectrum of wellness tenants.

In a new report, ICSC says the concept of wellness is less fuzzy than you might think.

The Global Wellness Institute (GWI), a Miami-based organization that seeks to educate the public and private sectors about preventative health and wellness, defines wellness as the pursuit of activities, choices and lifestyles that lead to a state of holistic health. The report states.

Wellness involves not merely physical health, but also mental, emotional, spiritual social, and environmental dimensions, according to ICSC. It also has a dimension of spending power: globally, wellness represented a $4.5-trillion economy in 2019, according to the GWI. Domestically, interest in wellness has spread from the Western U.S. to other regions.

ICSC says that key wellness segments often found in shopping centers include personal care, beauty and anti-aging; healthy eating, nutrition and weight loss; fitness and mind-body; preventative and personalized medicine and public health; and traditional and complementary medicine. Consumers heavily oriented toward wellness buy a wide array of often complementary services and products that sustain their lifestyles, including health food; supplements, vitamins, and minerals; anti-aging and other treatments such as facials, body scrubs, electrolysis, microdermabrasion, chemical peels and laser treatments; and alternative medical regimens.

Whether the goal is maintaining appearance and beauty or extending or merely preserving ones life, this is an array that shopping center landlords are scrutinizing with more avid interest than ever, ICSC says.

An ICSC survey has found that 73% of U.S. adults say living a healthy, well-balanced lifestyle in terms of their physical and mental well-being is more of a priority for them today than in the past.

The same ICSC survey reported that 39% of U.S. adults visited wellness tenants in shopping centers during the past year. They averaged 12 trips to wellness services in shopping centers during this perioda figure that rises to 31 trips when those who didnt visit these tenants at all are excluded. Cost and proximity were their top motivating factors for choosing a facility.

Read more at ICSC

Connect With ICSC

Get CRE News in 150 words

For comments, questions or concerns, please contact Paul Bubny

Tags: Healthcare, Retail, Weekender

healthcare retail weekender

united-states

For Retail Landlords, Time to Look Beyond Gyms to Wellness

Paul Bubny

Originally posted here:

For Retail Landlords, Time to Look Beyond Gyms to Wellness - ConnectCRE

A new market report by Market Research Intellect on the Complementary And Alternative Medicine Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period. The forecasts mentioned in the report have been acquired by using proven research assumptions and methodologies. Hence, this research study serves as an important depository of the information for every market landscape. The report is segmented on the basis of types, end-users, applications, and regional markets.

The research study includes the latest updates about the COVID-19 impact on the Complementary And Alternative Medicine sector. The outbreak has broadly influenced the global economic landscape. The report contains a complete breakdown of the current situation in the ever-evolving business sector and estimates the aftereffects of the outbreak on the overall economy.

Get Sample Copy with TOC of the Report to understand the structure of the complete report @ https://www.marketresearchintellect.com/download-sample/?rid=174144&utm_source=COD&utm_medium=888

The report also emphasizes the initiatives undertaken by the companies operating in the market including product innovation, product launches, and technological development to help their organization offer more effective products in the market. It also studies notable business events, including corporate deals, mergers and acquisitions, joint ventures, partnerships, product launches, and brand promotions.

Leading Complementary And Alternative Medicine manufacturers/companies operating at both regional and global levels:

Sales and sales broken down by Product:

Sales and sales divided by Applications:

The report also inspects the financial standing of the leading companies, which includes gross profit, revenue generation, sales volume, sales revenue, manufacturing cost, individual growth rate, and other financial ratios.

The report also focuses on the global industry trends, development patterns of industries, governing factors, growth rate, and competitive analysis of the market, growth opportunities, challenges, investment strategies, and forecasts till 2026. The Complementary And Alternative Medicine Market was estimated at USD XX Million/Billion in 2016 and is estimated to reach USD XX Million/Billion by 2026, expanding at a rate of XX% over the forecast period. To calculate the market size, the report provides a thorough analysis of the market by accumulating, studying, and synthesizing primary and secondary data from multiple sources.

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketresearchintellect.com/ask-for-discount/?rid=174144&utm_source=COD&utm_medium=888

The market is predicted to witness significant growth over the forecast period, owing to the growing consumer awareness about the benefits of Complementary And Alternative Medicine. The increase in disposable income across the key geographies has also impacted the market positively. Moreover, factors like urbanization, high population growth, and a growing middle-class population with higher disposable income are also forecasted to drive market growth.

According to the research report, one of the key challenges that might hinder the market growth is the presence of counter fit products. The market is witnessing the entry of a surging number of alternative products that use inferior ingredients.

Key factors influencing market growth:

Reasons for purchasing this Report from Market Research Intellect

Customized Research Report Using Corporate Email Id @ https://www.marketresearchintellect.com/need-customization/?rid=174144&utm_source=COD&utm_medium=888

Customization of the Report:

Market Research Intellect also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs.

Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

To summarize, the Complementary And Alternative Medicine market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Link:

Complementary And Alternative Medicine Market 2019 Break Down by Top Companies, Countries, Applications, Challenges, Opportunities and Forecast 2026 -...

In the contemporary moment of sex-positive feminism, praises for the orgasmic capacity of the vibrator abound. Theyre all-encompassing, a blanket of electricity, thatll course through your veins, producing orgasms you didnt know you were physically capable of having, wrote Erica Moen in her webcomic Oh Joy Sex Toy. Vibrators today go hand in hand with masturbation and female sexuality.

Yet for American housewives in the 1930s, the vibrator looked like any other household appliance: a nonsexual new electric technology that could run on the same universal motor as their kitchen mixers and vacuum cleaners. Before small motors became cheap to produce, manufacturers sold a single motor base with separate attachments for a range of household activities, from sanding wood to drying hair, or healing the body with electrical vibrations.

In my research on the medical history of electricity, vibrators appear alongside galvanic battery belts and quack electrotherapies as one of many quirky home cures of the early 20th century.

The first electromechanical vibrator was a device called a percuteur invented by British physician Joseph Mortimer Granville in the late 1870s or early 1880s. Granville thought that vibration powered the human nervous system, and he developed the percuteur as a medical device for stimulating ailing nerves.

[Image: New-York Tribune/Wiki Commons]Current medical opinion held that hysteria was a nervous disease, yet Granville refused to treat female patients, simply because I do not want to be hoodwinked . . . by the vagaries of the hysterical state. The vibrator began as a therapy for men only. It then quickly left the sphere of mainstream medical practice.

By the early 20th century, manufacturers were selling vibrators as ordinary electric household appliances. The merits of electricity in the home were not as obvious then as they are today: Electricity was dangerous and expensive, but it promised excitement and modernity. Electric commodities, such as sewing and washing machines, became the hallmarks of the rising middle class.

Vibrators were another shiny new technology, used to sell consumers on the prospect of modern electric living. Just as banks handed out free toasters for opening checking accounts in the 1960s, in the 1940s the Rural Electrification Administration distributed free vibrators to encourage farmers to electrify their homes. These modern electric devices were not thought of as sex toys.

In what may sound surprising to 21st-century readers, these appliances promised relief of a nonsexual variety. Users of all ages vibrated just about every body part, without sexual intent.

Vibrators made housework easier by soothing the pains of tired housewives, calming the cries of sick children, and invigorating the bodies of modern working men. They were applied to tired backs and sore feet, but also the throat, to cure laryngitis; the nose, to relieve sinus pressure; and everything in between. Vibration promised to calm the stomachs of colicky babies, and to stimulate hair growth in balding men. It was even thought to help heal broken bones.

A 1910 advertisement in the New York Tribune declared that Vibration Banishes Disease As the Sun Banishes Mist. In 1912, the Hamilton Beach New-Life vibrator came with a 300-page instructional guide titled Health and How to Get It, offering a cure for everything from obesity and appendicitis to tuberculosis and vertigo.

As such advertisements suggest, vibrators were not standard medical treatments, but medical quackery, alternative medicine that didnt deliver on their promises. Yet the electrical cure-alls sold by the millions.

The classic form of medical quackery in the U.S. market was patent medicinebasically useless concoctions made mainly of alcohol and morphine, sometimes containing downright damaging ingredients such as lead and arsenic. After the passage of the Pure Food and Drug Act in 1906, the federal government began regulating the sale of patent medicines.

Vibrators and other electrotherapies were not covered by the new law, so they took up the market share of older medical concoctions. The White Cross Vibrator replaced Mrs. Winslows Soothing Syrup as a popular home cure rejected by the medical establishment.

In 1915, the Journal of the American Medical Association wrote that the vibrator business is a delusion and a snare. If it has any effect it is psychology. The business was dangerous not because it was obscene, but because it was bad medicine. The potential, acknowledged by doctors, for the vibrator to be used in masturbation was just further evidence of its quackery.

Sex toy scholar Hallie Lieberman points out that nearly every vibrator company in the early 20th century offered phallic attachments that would have been considered obscene if sold as dildos. Presented instead as rectal or vaginal dilators, these devices were supposed to cure hemorrhoids, constipation, vaginitis, cervicitis, and other illnesses localized to the genitals and the anus. Hamilton Beach, for example, offered a special rectal applicator for an additional cost of $1.50 and recommended its use in the treatment of Impotence, PilesHemorrhoids, and Rectal Diseases.

The two most prominent scholars of vibrator history, Rachel Maines and Hallie Lieberman, argue that vibrators were always secretly sexual, but I disagree. Vibrators were popular medical devices. One of many medical uses of the vibrator was to cure diseases of sexual dysfunction. And this use was a selling point, not a secret, during an era of anti-masturbatory rhetoric.

Special vibrator attachments such as the rectal applicator offered dubious treatments for dubious diseases: remedies for ailments purportedly caused by ruinous and prevalent masturbation.

Masturbation was thought to cause diseases such as impotence in men and hysteria in women. Masturbatory illness was a pretty standard idea in the early 20th century. One of its surviving formulations is the idea that masturbating will make you go blind.

Theres no way to really know how people were using vibrators. But the evidence suggests that they signified medical treatment, not sinful masturbation, regardless of the use. Even if users were doing physical actions that people today think of as masturbation, they didnt understand themselves to be masturbating, and therefore they werent masturbating.

For most of the 20th century, vibrators remained innocuous quackery. Good Housekeeping even bestowed its seal of approval on some models in the 1950s. When the sexual revolution hit America in the 1960s, vibrators were largely forgotten, outdated appliances.

In the 1970s radical feminists transformed the vibrator from a relic of bygone domesticity to a tool of female sexual liberation. At Betty Dodsons bodysex workshops, electric vibrations changed feelings of guilt about masturbation to feelings of celebration so that masturbation became an act of self-love. She and her sisters embraced vibrators as a political technology that could convert frigid anorgasmic housewives into powerful sexual beings capable both of having multiple orgasms and destroying the patriarchy.

This masturbatory revolt erased the vibrators fading reputation as a cure for masturbatory illness and replaced it with a specific, powerful, public, and lasting linkage between the vibrator and female masturbatory practice.

Kim Adams is a postdoctoral lecturer in English at New York University. This article is republished from The Conversation under a Creative Commons license. Read the original article.

More here:

The surprising medical history of vibrators - Fast Company

ByHub staff report

University and Medicine leaders announced today that Johns Hopkins will pause the development of a police department for at least two years so that it may benefit from the national re-evaluation of policing in society brought about by the death of George Floyd at the hands of Minneapolis police.

"We want Johns Hopkins to be part of the conversation about what is possible for our city and country in rethinking the appropriate boundaries and responsibilities of policing, and to draw on the energies, expertise, and efforts of our community in advancing the agenda for consequential and enduring reform. And we want to be able to work nowwith a sense of shared purpose and commitment, with our neighbors, and across our university communityto develop and model these alternative approaches," wrote Ronald J. Daniels, president of the university; Paul B. Rothman, dean of the medical faculty and CEO of Johns Hopkins Medicine; and Kevin W. Sowers, president of the Johns Hopkins Health System and executive vice president of Johns Hopkins Medicine.

Read the full message below.

Dear Faculty, Students, Staff, and Neighbors of Johns Hopkins:

As hundreds of thousands rise in protest here and across the nation, we share the continued anguish and anger at the murder of George Floyd by Minneapolis police, and the unjust loss of so many other Black lives, in the long and grotesque history of systemic racism that has shaped this nation and its institutions.

This moment of national reckoning implicates all areas of our lives and the work we do together as a learned community. We recognize the ways in which systemic racism impacts unfairly our Black and Brown colleagues, neighbors, students, and staff. We know we must do more as an institution and as individuals to fully realize Johns Hopkins' core commitment to justice, equity, and inclusion, and we are grateful for the many difficult and important conversations that are happening now and that will guide our efforts to listen, to support, and to act.

Today, we want to speak to the renewed questions and broad concerns about policing in America and the calls to reconsider our decision to create a university police department at Johns Hopkins.

We sought the legislative authorization to build this department because of the sustained surge in violent crime directly impacting our students, faculty, staff, and neighbors and because, in contrast to our public university peers in the city, we lacked a police department that could help protect them. In seeking this authorization, we embraced without reservation many of the reforms that are now being called for across the country and we hope that legislation can contribute to the wider discussion of the steps needed to realize lawful, nonracist, and publicly accountable sworn policing.

The legislation that was enacted responded in a detailed and comprehensive manner to many of the concerns that were raised about the need for training to address racial bias, excessive force, and de-escalation, and the requirement for increased transparency and accountability. These issues are now very much at the center of the public debate over what modern policinghowever large or small its scopemust be in this country. Critically, the Johns Hopkins Police Department (JHPD) legislation explicitly enacted the best practices recommended by the national Task Force on 21st Century Policing and the Consent Decree that currently governs the Baltimore Police Department.

Throughout the process and again in recent weeks, we have been keenly aware of the range of principled and thoughtful perspectives on these issues, and we hear now the increasingly urgent calls for reconsideration of the way in which public safety in our community is achieved.

Many people see no role whatsoever for sworn policing in our country. Many others accept the necessity of some role for sworn policing but seek a fundamental and vigorous reimagination of how that role can be discharged equitably and integrated with other initiatives that ensure community safety.

We want Johns Hopkins to be part of the conversation about what is possible for our city and country in rethinking the appropriate boundaries and responsibilities of policing, and to draw on the energies, expertise, and efforts of our community in advancing the agenda for consequential and enduring reform. And we want to be able to work nowwith a sense of shared purpose and commitment, with our neighbors, and across our university communityto develop and model these alternative approaches.

Given the need for us to come together as a community in this enterprise of reimagining public safety, we have decided to pause for at least the next two years the implementation of the JHPD.

Taking the immediate implementation of the JHPD off the table is important for several reasons:

We hold with utmost seriousness our responsibility for the safety of our entire community, and in that spirit embrace the opportunity before us to allow that communityat Johns Hopkins, in our city, and well beyondto lend its intellectual and moral leadership in pointing a way forward on an issue that has so deeply riven this country.

In partnership and gratitude,

Ronald J. Daniels President

Paul B. Rothman, M.D.Dean of the Medical FacultyCEO, Johns Hopkins Medicine

Kevin W. Sowers, M.S.N., R.N., F.A.A.N.President, Johns Hopkins Health SystemEVP, Johns Hopkins Medicine

Read more:

Johns Hopkins will pause development of a police department for at least two years - The Hub at Johns Hopkins

The Kenya Medical Research Institute-KEMRI is awaiting final approvals to test its herbal medicine Zedupex for the management of Covid-19.

Deputy Director of the Centre for Traditional Medicine and Drug Research (CTMDR) at KEMRI, Dr. Peter Mwitari said Zedupex has already undergone its first review and is currently being evaluated before being given final approvals.

He said their proposal on the use of Zedupex for management of COVID 19 symptoms is undergoing an expedited process.

Mwitari is, however, urging the Ministry of Health to fast track formulation of legislation to guide alternative medicine practice in the country.

Get breaking news on your Mobile as-it-happens. SMS NEWS to 20153

He says lack of legislation to inform modalities on traditional medicine practice, has negatively impacted healthcare in the country.

Kemri is already banking on its herbal medicine Zedupex for management of the deadly virus.

The herbal drug developed in 2015 by the Kenyan researchers has been used for the treatment of herpes.

Dr. Mwitari, who was the chairperson of a technical working group that had been appointed to draft a policy document on traditional medicine and medicinal plants, said the team had finalized drafting the traditional and alternative health practitioners bill of 2019, and is now awaiting further directions from the health ministry.

Mwitari said had the legislation been finalized, it would have played a major role especially now when the country is battling the Covid-19 pandemic.

He said they have been getting several enquiries from traditional medicine practitioners who claim to have medicinal plants that may help in the management of Covid-19, but that they cannot be allowed access to Covid-19 patients as their herbs have no scientific proof of efficiency.

Mwitari said had there been legislation guiding the industry, more traditional medicine would have been researched and possibly get approvals on their treatment potential. The legislation will also help rid the industry of quacks.

Nonetheless, Dr.Mwitari said the center is currently awaiting necessary approvals on a second proposal that seeks to bring on board herbalists or any Kenyan who may have knowledge of a medicinal plant that has antiviral properties which may be researched on efficiency to manage some of the symptoms associated with Covid-19.

The approvals will also enable Kemri researchers to collect medicinal plants from practitioners for further analysis as well as documentation of their Traditional Medical Knowledge.

Medicinal plants

Mwitari called on the government to set aside more funds for research on traditional medicine, saying the sector can compliment the governments agenda of universal healthcare once legislation is put in place.

He said Kemris internal research grant has set aside 10 million shillings for research on the pandemic, and the amount is expected to be increased this new financial year.

Mwitari said there is documented evidence in Kenyas folklores that the practice has successfully been used by our forefathers for their healthcare needs including addressing previous pandemics.

He also said that medicinal plants account for up to 60 per cent of conventional medicine, hence the need for more research on their properties.

Mwitari cited the Artemisia annua plant for management of Malaria, The Madagascar periwinkle- which is the primary source of anti-cancer agent, Prunus Africana for managing prostate cancer, among others. Mwitari said he believes herbs may hold the key to Covid-19 cure once legislation is in place.

The world health organization-WHO is currently working with research institutions across the globe to select traditional medicine products which can be investigated for clinical efficacy and safety for Covid-19 treatment.

Madagascar has already come up with Covid-Organics, its herbal remedy for Covid 19. President Andry Rajoelina says that two injectable medications are already undergoing clinical trials.

A document summarizing the clinical trial protocol, published on the Pan African Clinical Trials Registry (PACTR) website, says that the trials have been registered in accordance with World health organization-WHO standards.

Follow this link:

Kemris Zedupex herbal drug to treat Covid-19 awaits final nod - Kenya Broadcasting Corporation